Lucknow: In a move to combat the growing threat of tuberculosis (TB) in Uttar Pradesh, the state health department has decided to expand its intensive TB detection campaign to cover all ...

In the battle against tuberculosis, a global scourge that claims over 1.5 million lives annually, researchers are looking to ...

Worldwide, approximately 2 million children younger than 15 years of age are infected with multidrug-resistant (MDR) Mycobacterium tuberculosis, with MDR tuberculosis developing in approximately ...

tuberculosis infection and disease in children following exposure to adults with multidrug-resistant (MDR) tuberculosis (TB). Methods: Cross-sectional study; all children aged < 5 years ...

But multidrug-resistant strains of tuberculosis, called MDR-TB, are becoming extremely dangerous and require more expensive and painful drugs to cure. A promising program in Lima, Peru ...

tuberculosis infection. The trial population comprised household contacts of persons with bacteriologically confirmed rifampicin-resistant or multidrug-resistant (MDR) tuberculosis in Vietnam.

For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected ...

To verify their suspicions, an X-ray test was carried out on Ebil’s respiratory system, which confirmed that Ebil had multi-drug resistant (MDR) tuberculosis. It is a strain of tuberculosis that ...

Bespite progress made, Nigeria faced a 60 percent funding gap in its tuberculosis (TB) response in 2023, posing significant ...

On world tuberculosis (TB) day, public health specialist Chapal Mehra describes the work of Dr Zarir Udwadia, who has been working tirelessly to fight the disease in its often untreatable forms.

BENGALURU -A critical medication for TB, or tuberculosis, will soon become more readily available and affordable for patients in India, and perhaps the world, after the Indian authorities rejected ...

MDR TB is caused by germs that are resistant to two or more of the main tuberculosis drugs -- isoniazid and rifampin.